GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (NYSE:ATR) » Definitions » 10-Year ROIIC %

ATR (AptarGroup) 10-Year ROIIC % : 8.35% (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is AptarGroup 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. AptarGroup's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was 8.35%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for AptarGroup's 10-Year ROIIC % or its related term are showing as below:

ATR's 10-Year ROIIC % is ranked better than
61.35% of 771 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs ATR: 8.35

AptarGroup 10-Year ROIIC % Historical Data

The historical data trend for AptarGroup's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AptarGroup 10-Year ROIIC % Chart

AptarGroup Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.31 4.17 4.41 5.94 8.35

AptarGroup Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8.35 - - -

Competitive Comparison of AptarGroup's 10-Year ROIIC %

For the Medical Instruments & Supplies subindustry, AptarGroup's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AptarGroup's 10-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where AptarGroup's 10-Year ROIIC % falls into.



AptarGroup 10-Year ROIIC % Calculation

AptarGroup's 10-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( 340.4492386 (Dec. 2023) - 192.7320122 (Dec. 2013) )/( 3717.675 (Dec. 2023) - 1948.779 (Dec. 2013) )
=147.7172264/1768.896
=8.35%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


AptarGroup  (NYSE:ATR) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


AptarGroup 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of AptarGroup's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


AptarGroup Business Description

Traded in Other Exchanges
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Executives
Monnas Giovanna Kampouri director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Kimberly Chainey officer: EVP and General Counsel 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Marc Prieur officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Stephan B. Tanda director, officer: President and CEO C/O PATHEON N.V., HERENGRACHT 483, AMSTERDAM P7 1017 BT
Hedi Tlili officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Gael Touya officer: Segment President 475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014
Shiela Vinczeller officer: Chief Human Resource Officer 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Robert Kuhn officer: EVP & CFO C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014
Xiangwei Gong officer: President, Asia 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010
Sarah Js Glickman director 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
George L Fotiades director 281 SUMMIT AVENUE, SUMMIT NJ 07901
Julie Xing director 265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014
Maritza Gomez Montiel director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Matthew L. Trerotola director 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Ralf K. Wunderlich director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014